baber/WOPTO huggingface dataset:
Patent GB-1339274-A (GB)
Title: Cleaning composition
IPC: C11D3/00
Filed: 1970-11-18
Abstract: 1339274 Heat-producing scouring powder UNILEVER Ltd 15 Nov 1971 [18 Nov 1970] 54791/70 Heading C5D A substantially dry particulate abrasive cleaning composition adapted to evolve heat when admixed with water, comprises at least 50% by wt. of finely-divided abrasive material and 0À5 to 10% by wt. of at least one anionic or nonionic detergent, the evolution of heat being caused by the presence in the cleaning composition of a chemical compound (A) in anhydrous form that hydrates exothermically on contact with water and the anhydrous chemical compound is present in an amount sufficient to ensure that the temperature rise that occurs during the mixing of 3 parts by wt. of the cleaning composition with 1 part by wt. of water is at least 10‹ C. but not greater than 50‹ C. The compound (A) may be (1) an alkaline earth metal halide, e.g. CaCl 2  and MgCl 2 ; (2) an alkali metal hydroxide, e.g. NaOH and KOH; (3) alkali metal salts of ortho silicates and sesquisilicates, aluminium sulphate and ferric chloride. The composition contains up to 99% wt. of an abrasive such as felspar, pumice, bentonite, talc or finely divided synthetic resin, e.g. polyethylene. Other ingredients are (B) alkali metal phosphates, polyphosphates, carbonates, bicarbonates, sesquicarbonates, borates and silicates, (C) chlorine bleaching agents (inorganic and organic), sodium perborate, sodium percarbonate and potassium monopersulphate, (D) inorganic fillers, sequestrants, anticaking agents and the like. The compound (A) may be coated with a nonionic surfactant, e.g. coconut monoethanolamide, a fatty acid, paraffin wax or a mineral oil.
Patent GB-1344401-A (GB)
Title: Flexible skirt assemblies for fluid cushion supported vehicles
IPC: B60V1/16
Filed: 1972-12-29
Abstract: 1344401 Air cushion vehicles BRITISH HOVERCRAFT CORP Ltd 29 Dec 1972 [12 Jan 1972] 1439/72 Heading B7K An air cushion vehicle has a flexible skirt 17 attached at its upper edge to the vehicle structure 12 and at its lower edge to an inflatable flexible cylindrical member 16 which is secured at intervals along its length by attachments 23 to curved inflatable flexible tubular members 11. The members 11 are inflated through non-return valves and secured at one end 13 in fixed housings in the vehicle structure and at the other end 14 they are movably mounted in flexible housings 15. Wear pads 18 are fitted to the lower face of member 16. In an alternative arrangement (Fig. 7, not shown) the interior of members 16 and 11 are in communication and cushion air discharge nozzles are formed on the lower surface of member 16 and supplied with air which is pumped into apertures in the ends 13 of members 11, thereby inflating the members 16 and 11. An inflatable pillow may be positioned between the upper face of member 16 and the vehicle structure.
Patent GB-1350584-A (GB)
Title: Binder compositions
IPC: B22C1/22
Filed: 1970-09-17
Abstract: 1350584 Silicic acid dispersion MONSANTO CHEMICALS Ltd 20 Aug 1971 [17 Sept 1970] 44466/70 Heading C1A [Also in Divisions C3 and D1-D2] A silicic acid dispersion comprises an aqueous solution of silicic acid (as defined) and a watersoluble organic polymer having a molecular weight greater than 4400, the silicic acid content as SiO 2  being at least 0À2% by weight. The polymer may be a vinyl-substituted heterocyclic N-containing polymer or copolymer of molecular weight 35,000 to 50,000, e.g. polyvinyl pyrrolidone or poly-2-vinyl-pyridene N-oxide or a polyalkylene glycol, e.g. a polyethylene glycol of molecular weight 10,000 to 25,000. In general the polymer should have a molecular weight between 5,000 and 200,000. The weight ratio of silicic acid to polymer may be from 150 : 1 to 2 : 1, and the pH of the dispersion should be less than 7. The stability of the silicic acid solution may be increased by contact with an anion-exchange resin in the hydroxyl form. The polymer may be added to the silicic acid as a finely divided solid or as a solution in a watermiscible solvent such as a lower alkanol (ethanol, methanol), a lower ketone (acetone) or an ether (tetrahydrofuran, ethoxyethanol). Addition of a silica aquasol having 1-65% by weight of SiO 2  produces a siliceous binding agent, for example in the production of a ceramic shell mould for metal casting.
Patent ID-30260-A (ID)
Inventor: VIHERVAARA TAPIO
IPC: D21H27/16
Filed: 1999-07-07
Abstract: The object of the invention is an additive for paper making by means of which the dusting tendency of paper can be reduced. The agent is based on starch, the molecular size of which has been reduced, and which has been cationized to a charge of less than 1.5 mEkv/g with a quaternary nitrogen compound. The agent is added to the fiber pulp for paper making prior to web formation.
Patent IL-100088-A (IL)
Title: Tnf inhibiting composition containing 1,3, 8-trisubstituted xanthine derivatives
IPC: A61P31/04
Filed: 1991-11-19
Abstract: Derivatives of 8-substituted xanthines are described which inhibit the production of TNF and are useful in the treatment of disease states mediated or exacerbated by TNF production.
[WO9209203A1]
Patent IL-103301-A (IL)
Title: Pyrimidine nucleoside derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
IPC: C07H19/073
Filed: 1992-09-30
Abstract: Anti-tumor compounds of the formula NHR1 N ON R3OO R5 OR2R4 in which: R1, R2 and R3 are the same or different and each represents a hydrogen atom, an alkanoyl group having from 2 to 24 carbon atoms, a substituted alkanoyl group which has from 2 to 24 carbon atoms and which is substituted by at least one of substituents A and/or substituents B, defined below, or an alkenylcarbonyl group having from 3 to 24 carbon atoms; provided that at least one of R1, R2 and R3 represents an unsubstituted alkanoyl group having from 5 to 24 carbon atoms, said substituted alkanoyl group or said alkenylcarbonyl group; one of R4 and R5 represents a hydrogen atom and the other represents a cyano group; said substituents A are selected from hydroxy groups, amino groups, mercapto groups, carboxy groups, protected amino groups, protected mercapto groups, azido groups, cyano groups, and halogen atoms; said substituents B are selected from alkoxy, alkoxyalkoxy, aralkyloxy, aliphatic carboxylic acyloxy, aromatic carboxylic acyloxy groups, alkoxycarbonyloxy, aralkyloxycarbonyloxy, haloalkoxycarbonyloxy, aryloxycarbonyloxy, tri-substituted silyloxy groups where the substituents are the same or different and each is an alkyl group having from 1 to 6 carbon atoms or an aryl group as defined below, alkylthio, arylthio, alkyldithio, aryldithio, aralkyldithio, alkylsulfonyloxy, aralsulfonyloxy, carbamoyl groups, and carbamoyloxy groups; said aryl groups are carbocyclic aryl groups having from 6 to 14 ring carbon atoms in at least one aromatic carbocyclic ring and which are unsubstituted or are substituted by at least one of substituents C, defined below; and said substituents C are selected from alkyl, alkoxy, aliphatic carboxylic acyl, halogen atoms, nitro groups, cyano groups, and amino groups, and pharmaceutically acceptable salts thereof and, where said substitutent A is a carboxy group, pharmaceutically acceptable esters thereof.
Patent IL-104926-A (IL)
Title: RF power amplifier with linearization
IPC: H03F1/32
Filed: 1993-03-02
Abstract: A radio transmitter circuit comprises a power amplifier (12) a lineariser circuit (10) for maintaining linearity in the power amplifier (12) and a feedback circuit (13) for feeding back a signal from an output of the power amplifier (12) to the linearising means for maintaining linearity, said power amplifier (12), lineariser circuit and feedback circuit forming a loop having adjustable loop linearisation parameters (for example phase and gain). A look-up table (19) is provided for storing predetermined loop linearisation parameters and a linear controller (18), coupled to the look-up table and the loop. The linear controller selects a loop linearisation parameter in response to a transmit control signal according to an operating condition input, such as battery level, frequency or temperature, at the time of receipt of the transmit control signal. Figure 2 shows an arrangement for detecting adjacent channel interference. <IMAGE>
Patent IL-106322-A (IL)
Title: Use of compounds which absorb and/or fluoresce in the IR region as markers for liquids
IPC: G01N/
Filed: 1993-07-13
Abstract: Use of compounds from the class of the phthalocyanines, naphthalocyanines, nickel dithiolene complexes, aminium compounds of aromatic amines, methine dyes or azulenesquaric acid dyes which have their absorption maximum in the range from 600 to 1,200 nm and/or a fluorescence maximum in the range from 620 to 1,200 nm, as markers for liquids, a process for detecting markers in liquids, and a detector suitable for this purpose.
Patent IL-115095-A (IL)
Title: POLYSUBSTITUTED THIAZOLO £3, 2-a| QUINOLINE AND -NAPHTHYRIDINE CARBOXYLIC ACID DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
IPC: A61K31/535
Filed: 1995-08-29
Abstract: New thiazolo[3,2-a]quinoline and thiazolo-[3,2-a]naphthyridine derivatives have the general formula (I), in which R<1>, R<2>, Z and X have the meanings given in the description. Also disclosed are a process for preparing the same and their use in bactericide agents.
[DE4431122A1]
Patent IL-115936-A (IL)
Title: Stress steering structure and method for manufacturing same
IPC: F16S5/00
Filed: 1995-11-09
Abstract: A load bearing structure having a set of uniform voids functions to resolve the forces imposed by developing compression in the material having the voids and minimizing the amount of tension developed in the material. For the voids to have this function, they must be deployed in a particular fashion. The voids are deployed to encompass a particular set of points. The set of points are such that each point in the matrix is spaced an equal distance from twelve and only twelve adjacent points of the matrix. The distance between the points does not matter as long as all are uniformly distanced in accordance with that rule. If the structure is considered to be composed of a closely packed set of hypothetical rhombic dodecahedra (RD) and the four edge vertices of each of those hypothetical RDs is truncated, the result will be a set of cubic voids. The center of each of those cubic voids will define the matrix referred to above and the cubic voids will serve to provide the optimum resolution of stress which minimizes the development of tension in the material. One in four of the hypothetical or mathematical RDs can be eliminated achieving the same force resolution result in a structure that contains less material. The shape and size, but not the position, of the voids can be varied with only slight loss in optimum stress resolution. Some voids can be omitted with only slight loss of optimum stress resolution.
Patent IL-120317-A (IL)
Title: Ciprofloxacin-hydrocortisone suspension
IPC: A61K9/00
Filed: 1996-06-05
Abstract: The invention is directed to an aqueous non-ototoxic, topical, otic pharmaceutical composition of matter for treating a mammal consisting essentially of: ciprofloxacin or a pharmaceutically acceptable salt thereof in aqueous solution in an amount effective for antibacterial action; hydrocortisone or a pharmaceutically acceptable salt thereof in an amount effective as an anti-inflammatory agent; polyvinyl alcohol at least about 85% hydrolyzed in an amount effective to suspend the hydrocortisone in solution; water sufficient to produce an aqueous composition; benzyl alcohol in an amount effective for antibacterial action; lecithin in an amount effective for enhancing suspension of other constituents in the composition; and polysorbate ranging from polysorbate 20 to 80 in an amount effective for spreading the preparation on a hydrophobic skin surface to the site of infection or inflammation.
Patent IL-131768-A (IL)
Title: Lockable guard for vending machine
IPC: G07F9/10
Filed: 1999-09-06
Abstract: A lockable guard (10) for a vending machine, comprising: a frame (12) fastenable to a vending machine; a locking bolt receiving member (16) secured to an inner surface of said frame; a cover member (20) hinged to said frame by means of a hinge (22); a lock (24) secured to said cover member; and a dead bolt (32) operatively connected to and actuable by said lock, said dead bolt being arranged for selective locking enegagement with said locking bolt receiving member.
Patent IL-149144-A (IL)
Title: Modified viral surface proteins which bind to cells of tumor vasculature
IPC: C12N15/48
Filed: 2002-04-15
Abstract: This invention relates to "targeted" viral or non-viral vector particles, including retroviral vector particles, adenoviral vector particles, adeno-associated virus vector particles, Herpes Virus vector particles, and pseudotyped viruses, and to non-viral vectors that contain a viral protein as part of a virosome or other proteoliposomal gene transfer vector. More particularly, this invention relates to viral and non-viral vector particles, including retroviral vector particles, adenoviral vector particles, adeno-associated virus vector particles, Herpes Virus vector particles, pseudotyped viruses, and non-viral vectors having a modified, or chimeric viral surface protein, such as, for example, a chimeric viral envelope polypeptide, wherein such modified viral surface protein, such as a modified viral envelope polypeptide, includes a peptide which is a tumor vasculature targeting motif or TVTM. The TVTM peptide may be placed between two consecutive amino acid residues of the viral surface protein, or may replace amino acid residues which have been removed from the viral surface protein. The term "polypeptide" as used herein means a polymer of amino acids and does not refer to any particular length of polymer. Such term also includes post-translationally modified polypeptides or proteins (e.g., glycosylated, acetylated, phosphorylated, etc.).
Patent IL-168365-A (IL)
Title: Use of a rasagaline with or without riluzole for preparing a medicament for treating amyotrophic lateral sclerosis
IPC: A61K31/428
Filed: 2005-05-03
Abstract: The subject invention provides a method for treating amyotrophic lateral sclerosis (ALS) in a subject in need of such treatment comprising administering to the subject R(+)-N-propargyl-1-aminoindan or a pharmaceutically acceptable salt thereof alone or in combination with 2-amino-6-trifluoromethoxy benzothiazole in amounts effective to treat ALS in the subject.
Patent IL-178478-A (IL)
Title: Pharmaceutical compositions containing anti-cd-3 antibodies
IPC: C07K16/28
Filed: 2006-10-05
Abstract: This invention provides method of treatment of autoimmune diseases and/or inflammatory disorders.
Patent IL-178705-A (IL)
Title: Fibers, nonwovens and articles containing nanofibers produced from high glass transition temperature polymers
IPC: D04H1/42
Filed: 2006-10-18
Abstract: The present invention is directed to nonwoven webs and articles comprising nanofibers. The nanofibers are made from a polymer having a glass transition temperature about 25 C. The nanofibers, having a diameter of less than 1 micron, may comprise a significant number of the fibers in one layer of the web contained by the article. Preferably, the nanofibers are produced in a melt film fibrillation process. Articles include diapers, training pants, adult incontinence pads, catamenials products such as feminine care pads and pantiliners, tampons, personal cleansing articles, personal care articles, and personal care wipes including baby wipes, facial wipes, and feminine wipes.
Patent IL-182012-A (IL)
Title: Monoclonal antibodies to progastrin, combinations thereof, hybridomas, pharmaceutical compositions comprising the antibodies, use of the pharmaceutical compositions, a progastrin immunoassay, a method of diagnosing a gastrin-promoted disease or condition and a method of monitoring treatment of gastrin-promoted disease or disorder
IPC: A61K/
Filed: 2007-03-19
Abstract: The present invention provides progastrin-binding molecules specific for progastrin that do not bind gastrin-17(G17), gastrin-34(G34), glycine-extended gastrin-17(G17-Gly), or glycine-extended gastrin-34(G34-Gly). Further, the invention provides monoclonal antibodies (MAbs) selective for sequences at the N-terminus and the C-terminus of the gastrin precursor molecule, progastrin and the hybridomas that produce these MAbs. Also provided are panels of MAbs useful for the detection and quantitation of progastrin and gastrin hormone species in immuno- detection and quantitation assays. These assays are useful for diagnosing and monitoring a gastrin-promoted disease or condition, or for monitoring the progress of a course of therapy. The invention further provides solid phase assays including immunohistochemical (IHC) and immunofluorescence (IF) assays suitable for detection and visualization of gastrin species in solid samples, such as biopsy samples or tissue slices. The progastrin-binding molecules are useful therapeutically for passive immunization against progastrin in progastrin-promoted diseases or conditions. Also provided are surrogate reference standard (SRS) molecules that are peptide chains of from about 10 to about 35 amino acids, wherein the SRS molecule comprises at least two epitopes found in a protein of interest of greater than about 50 amino acids. Such SRS molecules are useful as standards in place of authentic proteins of interest.
Patent IL-206483-A (IL)
Title: Use of an anti-angptl4 antagonist antibody in the preparation of a pharmaceutical composition for inhibiting proliferation of hepatocytes
Filed: 2010-06-20
Abstract: ANGPTL4 compositions and methods of using such compositions, and agonists or antagonists thereof, for the diagnosis and treatment of diseases or disorders are included, including methods to modulate cell proliferation, cell adhesion, and cell migration.
Patent IL-207878-A (IL)
Title: Use of a peptide for the production of antibodies for the treatment of alzheimer's disease
IPC: A61P25/28
Filed: 2010-08-30
Abstract: The invention relates to antibodies which are used in the preparation of a medicament for the treatment of Alzheimer's disease. More specifically, the invention relates to the use of an antibody specifically recognizing any one of the predominant variants of the amyloid beta peptide, Ab40 and Ab42, in the preparation of a medicament that is used to prevent and/or treat Alzheimer's disease.
Patent IL-221309-A (IL)
Title: Pharmaceutical compositions, combinations and kits comprising hmg-coa reductase inhibitors in combination with phosphodiesterase-4 inhibitors for the treatment of inflammatory pulmonary disease
Filed: 2012-08-05
Abstract: The invention relates to the combined use of a PDE4 inhibitor with a HMG-CoA reductase inhibitor for the preventive and curative treatment of an inflammatory pulmonary disease.
Patent JP-S59230677-A (JP)
Inventor: SHIMAZAKI KANZOU
IPC: B02B5/02
Filed: 1984-05-17
Abstract: (57)【要約】本公報は電子出願前の出願データであるた め要約のデータは記録されません。
Patent JP-S5724631-A (JP)
Title: Formation of compound by ion injection
Inventor: MAEYAMA SATOSHI
IPC: B01J19/08
Filed: 1980-07-22
Abstract: PURPOSE: To form a compound by injection of ions according to the number of atoms in a short time by using ions composed of plural atoms as an injection rate of ions.  
     CONSTITUTION: In a method of forming a compound in which a base material is subjected to an ion injection treatment using elements different from the constituent elements of the base material or a substance containing the elements, ions composed of a large number of atoms more than two or more the constituent elements or the  elements of the substance containing the constituent elements are used as an injection rate of ions during the ion injection treatment. Thus, an objective compound  with stoichiometric composition ratio can be formed in a short time according to the  number of the atoms. 
     COPYRIGHT: (C)1982,JPO&Japio
Patent JP-S584867-A (JP)
Inventor: MORIKAWA TAKASHI
IPC: D06C23/04
Filed: 1981-06-30
Abstract: (57)【要約】本公報は電子出願前の出願データであるた め要約のデータは記録されません。
Patent JP-H06343030-A (JP)
Title: 3-terminal switching means
Inventor: SUZUKI TOSHIYASU
IPC: H03K17/73
Filed: 1994-04-05
Abstract: PURPOSE:To delay a turn-on action without increasing the turn-off delay by connecting in series two non-controllable switches connected in parallel to the resistors between the control terminals and then connecting both control terminals and the main terminals paired as the drive terminals to each other. CONSTITUTION:When a terminal 4 is biased to a terminal 3 in a plus state, a transistor TR 2 is immediately and adversely biased via a diode 6. However a TR 1 is forward biased with delay via a resistor 7. When the terminal 4 is biased to the terminal 3 in a minus state, the TR 1 is immediately and adversely biased via a diode 5. However the TR 2 is forward biased with delay via a resistor 8. Thus the resistor 7 or 8 limits only the charging/discharging current of the gate-source capacitance of the forward bias side. So that the turn-off action of each resistor can be delayed with increasing its turn-off delay.
Patent JP-H01271529-A (JP)
Title: Automatic offsetting mechanism of small revolution type backhoe
Inventor: NAKANO YOSHIKI
IPC: E02F3/43
Filed: 1988-04-22
Abstract: PURPOSE:To enhance the safety by folding a boom and an arm for accommodation of a bucket at the side of a cabin, and returning the bucket automatically to the accommodation position with maneuvering of a control lever to the accommodation side. CONSTITUTION:When the offset prohibited area as a hazardous area is approached, a boom solenoid proportional valve 37 and an arm solenoid proportional valve 38 are switched over to the port on the opposite side to operation of a manual control valve so as to stop rotation, when an offset solenoid proportional valve 39 is solely turned on. Then the level of a bucket 1 is checked to know whether or not the level is over the setting given by a bucket level setting switch 34. When an arm control lever 9a or a boom control lever is tuned fully, the proportional valve 39 is actuated to cause commencement of automatic return of bucket 1 to the accommodation position. When the bucket 1 is restituted to the standard position, the proportional valve 39 is switched over to the neutral.
Patent JP-H05271580-A (JP)
Title: Aqueous coating composition
IPC: C09D5/00
Filed: 1992-03-26
Abstract: PURPOSE:To obtain the subject composition, comprising prescribed amounts of an aqueous resin, a curing agent, a metallic pigment and a specific corrosion inhibitor, excellent in corrosion, water and chemical resistances, storage stability and adhesion and useful for automobiles, etc. CONSTITUTION:The objective composition comprises (A) an aqueous resin such as an acrylic resin, (B) a curing agent such as melamine, (C) a metallic pigment such as aluminum and (D) a phosphoric acid ester, composed of a copolymer obtained from (i) an ethylenic monomer containing one or more acidic hydroxyl groups bound to phosphorus atom in the molecule, (ii) an ethylenic monomer containing hydroxyl group and (iii) other ethylenic monomers copolymerizable therewith and having one or more acidic hydroxyl groups bound to the phosphorus atom and/or their salts, 30-150mgKOH/g acid value, 30-150mgKOH/g hydroxyl value and 3000-15000 number-average molecular weight as a corrosion inhibitor for the component (C). The content of the phosphoric acid ester is 0.2-10wt.% expressed in terms of orthophosphoric acid, based on the component (C).